By The Blaze ——Bio and Archives--February 2, 2023
News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us
Merck & Co.'s COVID-19 pill Lagevrio may be helping to generate and spread new variants, according to a new study. These mutant spin-offs could possibly turn out to be potentially more contagious and deadly than the virus the drug was originally supposed to combat.
Molnupiravir, sold as Lagevrio, is an antiviral drug from Merck & Co. and Ridgeback Biotherapeutics. It is supposed to prevent RNA viruses from replicating by inducing mutations in the virus genome during replication. The National Institutes of Health claimed that this pill had "shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials."---More...
Support Canada Free Press
View Comments
Blaze Media is news and entertainment for people who love America. As one of the nation’s largest independent media companies, Blaze Media reaches over 165 million people each month through radio, podcasts, Roku, Amazon Fire, Apple TV, social media, email newsletters, and the web.